Brain Research 1997-01-23

Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression.

L J Munro, L Kokkinidis

Index: Brain Res. 746 , 231-238, (1997)

Full Text: HTML

Abstract

Dopamine (DA) D2 and gamma-aminobutyric acid (GABA)A somatodendritic receptors tonically inhibit mesolimbic projection neurons in the A10 DA cell grouping of the ventral tegmentum. In the present study we determined the contribution of the ventral tegmental area (VTA) to the expression of a classically conditioned fear-induced increase in the acoustic startle reflex. Saline applied to VTA neurons did not modify the capacity of a light previously associated with footshock to potentiate acoustic startle amplitudes; conversely, bilateral administration of the DA D2/3 agonist quinpirole or the GABAA receptor agonist muscimol into the ventral tegmentum blocked fear-potentiated startle without altering baseline acoustic startle responding. It was suggested that DA VTA neurons regulate the excitatory aspects of fear expression by gating levels of aversive emotional arousal within the amygdala-based fear system.


Related Compounds

  • Quinpirole dihydro...
  • (-)-Quinpirole hyd...

Related Articles:

Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae.

2011-04-06

[J. Neurosci. 31 , 5512-25, (2011)]

A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

2015-04-01

[Hum. Mol. Genet. 24(7) , 1929-44, (2015)]

Biphasic effect of D-2 agonist quinpirole on locomotion and movements.

1989-02-28

[Eur. J. Pharmacol. 161 , 151-157, (1989)]

Compounds selective for dopamine receptor subtypes. Kebabian, et al.

[Drug Discov. Today 2 , 333-340, (1997)]

K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.

1995-08-01

[Pharmacol. Biochem. Behav. 51 , 843-848, (1995)]

More Articles...